nsv3884269
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:copy number variation
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:2
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:14,929
- Description:
See descriptions for individual calls in download files - Publication(s):Gaedigk et al. 1991, Goetz et al. 2018, Gough et al. 1990, Idle et al. 2000, Lyon et al. 2012, Nelson et al. 2004, Steen et al. 1995, Swen et al. 2011
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 199 SVs from 40 studies. See in: genome view
Overlapping variant regions from other studies: 302 SVs from 59 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Outer Start | Inner Start | Inner Stop | Outer Stop |
---|---|---|---|---|---|---|---|---|---|---|---|
nsv3884269 | Remapped | Perfect | GRCh38.p12 | ALT_REF_LOCI_3 | First Pass | NT_187682.1 | Chr22|NT_1 87682.1 | 45,535 | 48,309 | 57,692 | 60,463 |
nsv3884269 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000022.10 | Chr22 | 42,519,196 | 42,521,970 | 42,531,353 | 42,534,124 |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv15119735 | deletion | Multiple | Multiple | Debrisoquine, poor metabolism of | drug response | ClinVar | RCV000018386.24, VCV000016890.2 |
nssv16215093 | deletion | Multiple | Multiple | Tamoxifen response | drug response | ClinVar | RCV001093715.1, VCV000016890.2 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Outer Start | Inner Start | Inner Stop | Outer Stop |
---|---|---|---|---|---|---|---|---|---|---|---|
nssv15119735 | Remapped | Perfect | NT_187682.1:g.(455 35_48309)_(57692_6 0463)del | GRCh38.p12 | First Pass | NT_187682.1 | Chr22|NT_1 87682.1 | 45,535 | 48,309 | 57,692 | 60,463 |
nssv16215093 | Remapped | Perfect | NT_187682.1:g.(455 35_48309)_(57692_6 0463)del | GRCh38.p12 | First Pass | NT_187682.1 | Chr22|NT_1 87682.1 | 45,535 | 48,309 | 57,692 | 60,463 |
nssv15119735 | Submitted genomic | NC_000022.10:g.(42 519196_42521970)_( 42531353_42534124) del | GRCh37 (hg19) | NC_000022.10 | Chr22 | 42,519,196 | 42,521,970 | 42,531,353 | 42,534,124 | ||
nssv16215093 | Submitted genomic | NC_000022.10:g.(42 519196_42521970)_( 42531353_42534124) del | GRCh37 (hg19) | NC_000022.10 | Chr22 | 42,519,196 | 42,521,970 | 42,531,353 | 42,534,124 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv15119735 | GRCh37: NC_000022.10:g.(42519196_42521970)_(42531353_42534124)del | deletion | germline | Debrisoquine, poor metabolism of | drug response | ClinVar | RCV000018386.24, VCV000016890.2 |
nssv16215093 | GRCh37: NC_000022.10:g.(42519196_42521970)_(42531353_42534124)del | deletion | germline | Tamoxifen response | drug response | ClinVar | RCV001093715.1, VCV000016890.2 |